Back to search results

CTSN Embolic Protection Trial

Abroad (travel likely)Recruiting

Conditions

Delirium · Ischemic Stroke · Acute Kidney Injury · Heart Valve Disease · Coronary Artery Disease

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • CHI St. Vincent Heart Institute, North Little Rock, Arkansas, United States

    Contact: Study coordinator (Lynn Bass) · Lynn.bass@commonspirit.org
    Contact: Principal Investigator (Thurston Bauer)

  • Keck Hospital of the University of Southern California, Los Angeles, California, United States

    Contact: Study coordinator (Edward Lozano) · edwardlo@med.usc.edu
    Contact: Principal Investigator (Vaughn Starnes)

  • Emory University, Atlanta, Georgia, United States

    Contact: Study coordinator (Sonya Mathewson) · sbmathe@emory.edu
    Contact: Principal Investigator (Michael Halkos)

  • Indiana University, Bloomington, Indiana, United States

  • Indiana Ohio Heart, Fort Wayne, Indiana, United States

  • Ochsner Clinic, New Orleans, Louisiana, United States

    Contact: Study coordinator (Nicolle Scholl) · nicolle.scholl@ochsner.org
    Contact: Principal Investigator (Eugene Parrino)

  • Maine Medical Center, Portland, Maine, United States

    Contact: Study coordinator (Monica Palmeri) · Monica.Palmeri@mainehealth.org
    Contact: Principal Investigator (Ansar Hassan)

  • Johns Hopkins Medicine, Baltimore, Maryland, United States

    Contact: Study coordinator (Lisa Fornaresio, PhD) · lisa.fornaresio@jhmi.edu
    Contact: Principal Investigator (James S Gammie)

  • University of Maryland, College Park, Maryland, United States

    Contact: Study coordinator (Kaitlyn Masih) · KMasih@som.umaryland.edu
    Contact: Principal Investigator (Mehrdad Ghoreishi)

  • Massachusetts General Hospital, Boston, Massachusetts, United States

    Contact: Study coordinator (Ana M Pico) · APICO@mgh.harvard.edu
    Contact: Principal Investigator (Nathaniel Langer)

  • University of Michigan, Ann Arbor, Michigan, United States

    Contact: Study coordinator (China Green) · chjgreen@med.umich.edu
    Contact: Principal Investigator (Gorav Ailawadi)

  • Mayo Clinic, Rochester, Minnesota, United States

    Contact: Study coordinator (Jennifer Martin) · Martin.Jennifer2@mayo.edu
    Contact: Principal Investigator (Paul Tang)

  • Saint Luke's Hospital of Kansas City, Kansas City, Missouri, United States

    Contact: Study coordinator (Rosann Gans) · rgans@saint-lukes.org
    Contact: Principal Investigator (Keith Allen)

  • Columbia University Medical Center, New York, New York, United States

    Contact: Study coordinator (Bo Lu) · bl2699@cumc.columbia.edu
    Contact: Principal Investigator (Isaac George)

  • New York Presbyterian-Cornell Medical Center, New York, New York, United States

  • NYU Langone Hospital Brooklyn, New York, New York, United States

  • Northwell Health, New York, New York, United States

    Contact: Study coordinator (Kristine Gowan) · KMcGowan@northwell.edu
    Contact: Principal Investigator (Pey-Jen Yu)

  • Montefiore Medical Center, The Bronx, New York, United States

    Contact: Study coordinator (Agnieszka Siemienik) · asiemien@montefiore.org
    Contact: Principal Investigator (Daniel Goldstein)

  • Duke University, Durham, North Carolina, United States

    Contact: Study coordinator (Mary Motta) · mary.motta@duke.edu
    Contact: Principal Investigator (Jeffrey Gaca)

  • University Hospitals, Cleveland, Ohio, United States

  • Cleveland Clinic, Cleveland, Ohio, United States

    Contact: Study coordinator (Anna M Simmons) · SIMMONA8@ccf.org
    Contact: Principal Investigator (Marc Gillinov)

  • Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, United States

    Contact: Study coordinator (Mary L Mayer) · marylou.mayer@uphs.upenn.edu
    Contact: Principal Investigator (Michael Acker)

  • University of Virginia, Charlottesville, Virginia, United States

    Contact: Study coordinator (Ashley Fox) · ATF4C@uvahealth.org
    Contact: Principal Investigator (John Kern)

  • West Virginia University, Morgantown, West Virginia, United States

    Contact: Study coordinator (Misa Shaw) · misa.shaw1@wvumedicine.org
    Contact: Principal Investigator (James Mehaffey)

  • London Health Sciences Centre, London, Ontario, Canada

    Contact: Study coordinator (Stephanie Fox) · Stephanie.Fox@lhsc.on.ca
    Contact: Principal Investigator (Michael Chu)

  • University of Ottawa Heart Institute, Ottawa, Ontario, Canada

    Contact: Study coordinator (Nahya Awada) · naawada@ottawaheart.ca
    Contact: Principal Investigator (Pierre Voisine)

  • Montreal Heart Institute, Montreal, Quebec, Canada

    Contact: Study coordinator (Alexandre Bergeron) · Alexandre.Bergeron.icm@icm-mhi.org
    Contact: Principal Investigator (Denis Bouchard)

  • Hôpital Laval, Québec, Quebec, Canada

    Contact: Study coordinator (Annie Bergeron) · annie.bergeron@criucpq.ulaval.ca
    Contact: Principal Investigator (Pierre Voisine)
Study leads

  • Annetine C. Gelijns, PhD

    Principal Investigator

    Icahn School of Medicine at Mount Sinai

  • Steve Messe, MD

    Principal Investigator

    University of Pennsylvania

  • Alexander Iribarne, MD

    Principal Investigator

    Northwell Health

View source on ClinicalTrials.gov(opens in a new tab)